Last Posted: Mar 04, 2023
- Genomic profiling in amyloid light-chain amyloidosis reveals mutation profiles associated with overall survival.
Huang Xu-Fei, et al. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2019 0 (1) 36-44
- Daratumumab activity in relapsed or primary refractory systemic AL amyloidosis and Fc? receptor 3A V158F polymorphisms.
Xingguang Lee Lisa, et al. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2019 0 (2) 101-102
- AL amyloidosis with a localized B cell neoplasia.
Stuhlmann-Laeisz Christiane, et al. Virchows Archiv : an international journal of pathology 2019 0 (3) 353-363
- Search for AL amyloidosis risk factors using Mendelian randomization.
Saunders Charlie N, et al. Blood advances 2021 0 (13) 2725-2731
- Lessons from Four Decades of Systemic Amyloidosis with Renal Involvement.
Oliveira-Silva Catarina, et al. Nephron 2022 0 1-12
- Prevalence, mutational spectrum and clinical implications of clonal hematopoiesis of indeterminate potential in plasma cell dyscrasias.
Testa Stefano, et al. Seminars in oncology 2022 0
- Left ventricular assessment in patients with systemic light chain amyloidosis: a 3-dimensional speckle tracking transthoracic echocardiographic study.
Pradel Sarah, et al. The international journal of cardiovascular imaging 2019 0 (5) 845-854
- Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies.
Milandri Agnese, et al. European journal of heart failure 2020 0 (3) 507-515
- Utility of Bruton's Tyrosine Kinase Inhibitors in Light Chain Amyloidosis Caused by Lymphoplasmacytic Lymphoma (Waldenström's Macroglobulinemia).
Bou Zerdan Maroun, et al. Advances in hematology 2022 0 1182384
- Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.
Adams David et al. Journal of neurology 2020 Jan
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 25, 2023
- Content source: